Accessibility Links

Find more case studies

Strong Demand for Private Premium Healthcare in Hong Kong and the Region

Top-notch private hospital set up in the city to provide all-inclusive and fixed price medical packages and contribute to the training and development of healthcare professionals and advancement of clinical research

Located at Wong Chuk Hang on Hong Kong Island South, the Gleneagles Hong Kong Hospital (“GHK”) opened in March 2017 and features 500 beds, cutting-edge medical technologies and a comprehensive range of clinical services spanning more than 35 specialties and subspecialties.

Strong Demand for Private Premium Healthcare in Hong Kong and the Region

GHK is a partnership between Parkway Pantai, a wholly owned subsidiary of IHH Healthcare Berhad, and NWS Holdings with Li Ka Shing Faculty of Medicine of The University of Hong Kong (“HKU”) as its clinical partner.

According to Dr Tan See Leng, Managing Director & Chief Executive Officer at IHH Healthcare, and Group Chief Executive Officer and Managing Director of Parkway Pantai Limited, Hong Kong has a growing and ageing population, increasing private insurance coverage and shifting disease profiles towards the more chronic and complex medical conditions. These have all contributed to pent-up demand for more treatment options outside the public sector.

“It was a natural extension of the group’s strategy of expanding in Hong Kong with a strong and growing demand for premium private healthcare. We are proud to complement the robust public healthcare infrastructure with the opening of our flagship Gleneagles Hong Kong Hospital,” Dr Tan said.

At the initial stage, the hospital offers 54 all-inclusive and fixed price medical packages and aims to progressively increase the number of packages to over 150 that can cater for more critical conditions such as cancer and heart diseases. It also differentiates itself by delivering superior clinical outcomes and best-in-class care for patients, supported by a transparent and competitive fee structure that gives them peace of mind. As part of the uniquely successful ‘Gleneagles Hospital’ brand, the hospital is also able to offer an integrated suite of healthcare services, deep expertise in taking on complex cases, and sharing of best practice and medical knowledge.

From a longer-term perspective, the Greater China region is a priority key market for the hospital group. The opening of GHK is therefore a key milestone on this journey, which began more than 10 years ago. InvestHK provided information and invited the company to participate in the private hospital development in Hong Kong back in 2010 and has established a long term relationship since then. With Gleneagles Chengdu, Gleneagles Nanjing and Gleneagles Shanghai on the Mainland to progressively open over the next few years, IHH Healthcare is well‑positioned to meet the rapidly growing demand in the region.

Friday, May 19, 2017

Further Reading (Please click here to download Acrobat Reader)

Fast Facts

  • Opened in March 2017, Gleneagles Hong Kong Hospital (GHK) is a partnership between Parkway Pantai and NWS Holdings with Li Ka Shing Faculty of Medicine of The University of Hong Kong (HKU) as its clinical partner
  • Provides 500 beds, cutting-edge medical technologies and a comprehensive range of clinical services spanning more than 35 specialties and sub-specialties

Want to know more?

Visit the forum and engage with our friendly & knowledgable business set up community for help and advice.

Visit our Why HK Forum

Contact General Enquiries

www.investhk.gov.hk Hong Kong